Jubilant Life Sciences has issued Commercial Papers (CPs) worth Rs 75 crore on April 23, 2018. The company has issued two Papers, one worth Rs 50 crore and other worth Rs 25 crore.
The tenure of instrument is 29 days for Paper worth Rs 50 crore and will mature on May 22, 2018, while the tenure of instrument is 38 days for Paper worth Rs 25 crore and will mature on May 31, 2018.
Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.